Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells
Ce Luo(Peking University), Zexian Zeng(Peking University), Wubing Zhang(California Institute for Regenerative Medicine), Yiteng Jin(Peking University), Qiang Pan‐Hammarström(Karolinska Institutet), Zhidong Gao(Peking University), Luhua Lai(Peking University), Chenfei Wang(Shanghai Jiao Tong University), Sitong Ye(Yale University), Zongxu Zhang(Peking University), Rui Zhang(Center for Life Sciences), Xiaohong Li(New York State Office for People With Developmental Disabilities), Dian Li(Fudan University), Rui Guo(Sun Yat-sen University), Peng Zhang(Nanjing Tech University), Teng Xue(Nanjing Medical University), Lijian Wu(Dana-Farber Cancer Institute), Yanping Zhao(Fujian Medical University), Dengyu Pan(Shanghai University), Yufeng He(Center for Life Sciences), Kai W. Wucherpfennig(Brigham and Women's Hospital)
Cited by 31
Related Papers
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.4k
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase
|Journal of Biological Chemistry|2004|349